Table 2.
Correlation between PET indices and serum inflammatory biomarker levels in untreated and treated SpA patients
| PET indices (n = 24) | CRP (n = 24) | ESR (n = 15) | MMP-3 (n = 18) | ||||
|---|---|---|---|---|---|---|---|
| ρ | P | ρ | P | ρ | P | ||
| Untreated SpA | MaxSUVmax | 0.771 | < 0.001 | 0.527 | 0.043 | 0.449 | 0.062 |
| Number of positive regions | 0.644 | < 0.001 | 0.514 | 0.050 | 0.499 | 0.035 | |
| Total score | 0.684 | < 0.001 | 0.534 | 0.040 | 0.551 | 0.018 | |
| PET indices (n = 12) | CRP (n = 12) | ESR (n = 6) | MMP-3 (n = 8) | ||||
|---|---|---|---|---|---|---|---|
| ρ | P | ρ | P | ρ | P | ||
| Treated SpA | MaxSUVmax | 0.434 | 0.159 | 0.429 | 0.397 | − 0.143 | 0.736 |
| Number of positive regions | 0.326 | 0.301 | 0.493 | 0.321 | 0.156 | 0.713 | |
| Total score | 0.396 | 0.203 | 0.429 | 0.397 | 0.071 | 0.867 | |
SpA Spondyloarthritis; SUVmax Maximum standardized uptake value; CRP C-reactive protein; ESR Erythrocyte sedimentation rate; MMP-3 Matrix metalloproteinase 3